文献速递脊柱关节炎

吸烟对中轴型脊柱关节炎患者TNF抑制剂应答的影响:纵向观察性研究的方法学考量

Impact of Smoking in Response to Tumor Necrosis Factor Inhibitors in Axial Spondyloarthritis: Methodologic Considerations for Longitudinal Observational Studies.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2020-03-12

本研究基于英国风湿病学会生物制剂注册中轴型脊柱关节炎队列,分析840例首次使用TNF抑制剂(TNFi)的患者,采用加权广义估计方程和逆概率权重校正基线差异及剔除偏倚。结果显示,校正基线差异后,当前吸烟者和既往吸烟者与从不吸烟者的TNFi应答(BASDAI和ASDAS变化)无差异。既往研究结果矛盾可能源于方法学差异,未来研究需注意潜在偏倚。

要点

  • 校正基线差异后,吸烟状态不影响中轴型脊柱关节炎患者对TNFi的应答。
  • 当前吸烟者和既往吸烟者基线疾病活动度较从不吸烟者更差。
  • 观察性研究分析TNFi应答时需采用逆概率权重等方法控制偏倚。

核心结论

  • 在英国队列中,中轴型脊柱关节炎患者首次使用TNFi后,应答不因基线吸烟状态而异。
  • 既往研究结果的矛盾可能源于方法学差异,未来研究应处理潜在偏倚来源。

研究设计与样本

  • 纵向观察性研究,数据来自英国风湿病学会强直性脊柱炎生物制剂注册。
  • 纳入符合ASAS中轴型SpA标准且首次使用TNFi的参与者,共840人开始治疗,分析627人的1641次评估。
  • 采用加权广义估计方程比较吸烟状态对连续结局的影响,并用逆概率权重校正基线协变量差异和剔除参与者。
  • 单独评估前3个月应答以处理非随机脱落。

主要发现

  • 627名分析对象中69%为男性,平均年龄46岁;33%为当前吸烟者,30%为既往吸烟者。
  • 既往吸烟者和当前吸烟者基线疾病状态较从不吸烟者更差。
  • 校正基线差异后,与从不吸烟者相比,既往吸烟者BASDAI应答β=-0.6(95%CI -1.4, 0.3),当前吸烟者β=-0.4(95%CI -1.1, 0.4)。
  • ASDAS应答:既往吸烟者β=-0.1(95%CI -0.5, 0.3),当前吸烟者β=-0.01(95%CI -0.4, 0.4)。

关键数值与推荐

  • BASDAI和ASDAS变化用于评估应答,校正后吸烟状态间无显著差异。

临床怎么用

  • 临床中不应仅根据吸烟状态预测中轴型脊柱关节炎患者对TNFi的应答。
  • 解读观察性研究时需考虑基线差异和脱落偏倚对结果的影响。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Observational data facilitate examination of treatment-effect heterogeneity, but the risk of bias is substantial. The present study was undertaken to highlight methodologic considerations through an analysis of whether smoking affects response to tumor necrosis factor inhibitors (TNFi) in axial spondyloarthritis (SpA). METHODS: We used longitudinal data from the British Society for Rheumatology Biologics Register for Ankylosing Spondylitis. Participants fulfilling the Assessment of SpondyloArthritis international Society criteria for axial SpA who started their first TNFi were eligible for analysis. In comparing the impact of smoking status, weighted generalized estimating equations were used to examine changes in several continuous outcome measures, including the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Ankylosing Spondylitis Disease Activity Score (ASDAS). Inverse probability weights were used to account for differences in baseline covariates and excluded participants. We separately assessed response in the first 3 months to account for nonrandom dropout. RESULTS: For 840 participants who started on TNFi, 1,641 assessments from 627 individuals were analyzed (69% male, mean age 46 years). A total of 33% were current smokers and 30% ex-smokers. Ex-smokers and current smokers had worse disease than never smokers at baseline. Accounting for these differences, response did not differ according to smoking status. Compared to never smokers, ex-smokers (β = -0.6, 95% confidence interval [95% CI] -1.4, 0.3) and current smokers (β = -0.4, 95% CI -1.1, 0.4) had a similar response according to the BASDAI and ASDAS (ex-smokers β = -0.1, 95% CI -0.5, 0.3; current smokers β = -0.01, 95% CI -0.4, 0.4) at 3 months. CONCLUSION: TNFi response did not differ according to baseline smoking status in this UK cohort. Conflicting results from previous studies were likely due to methodologic differences. This analysis highlights potential sources of bias that should be addressed in future studies.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Zhao SS, Yoshida K, Jones GT, et al. Impact of Smoking in Response to Tumor Necrosis Factor Inhibitors in Axial Spondyloarthritis: Methodologic Considerations for Longitudinal Observational Studies. Arthritis Care Res (Hoboken). 2020. PMID: 30762311. doi:10.1002/acr.23851

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。